(ADDV-A) ADDvise - Ratings and Ratios
Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0001306119
ADDV-A EPS (Earnings per Share)
ADDV-A Revenue
ADDV-A: Medical Devices, Laboratory Equipment, Pharmaceutical Products, Surgical Instruments, Rehabilitation Equipment
ADDvise Group AB (publ) is a multifaceted medical device and equipment supplier catering to a broad customer base across the globe, including public and private laboratories, research facilities, healthcare institutions, and pharmaceutical companies. The companys diverse product portfolio encompasses laboratory furniture, protective ventilation systems, climate-controlled clean rooms, and laboratory equipment, as well as medical equipment, consumables, and pharmaceuticals tailored to specific medical areas such as urology, gynecology, emergency care, and surgery.
Beyond its product supply business, ADDvise Group AB (publ) is also engaged in the rental and sale of medical equipment, distribution of specialized instruments and consumables for the life-science and biopharma sectors, and the design, construction, and installation of customized cleanrooms and air conditioning systems. Additionally, the company develops, manufactures, and markets a range of products including glucose monitors and insulin pumps for diabetic patients, products for rescue and rehabilitation operations, implants, instruments, and technologies for surgical precision, and disposable medical devices.
The companys operations extend into the pharmaceutical sector through its mail-order pharmacy specializing in mens health medications, and the development, manufacture, and marketing of over-the-counter generic drugs for various health conditions. This broad spectrum of activities positions ADDvise Group AB (publ) as a comprehensive solutions provider in the healthcare and life sciences industries.
From a technical analysis perspective, the stocks current price is 3.11 SEK, below its SMA20 and SMA50 of 3.23 SEK, indicating a potential short-term bearish trend. The SMA200 at 4.17 SEK suggests a longer-term downtrend. The ATR of 0.20 SEK, or 6.32%, indicates moderate volatility. Given the 52-week high of 8.00 SEK and low of 2.37 SEK, the stock is currently trading near the lower end of its recent range, potentially signaling undervaluation or a bearish outlook.
Fundamentally, ADDvise Group AB (publ) has a market capitalization of 569.00M SEK, with a P/E ratio of 30.82 and a forward P/E of 20.45, suggesting that the stock may be relatively expensive compared to its current earnings but is expected to become more reasonably valued in the future. The Return on Equity (RoE) of 9.12% indicates a moderate level of profitability in terms of shareholder equity.
Forecasting the future performance of ADDV-A stock involves considering both technical and fundamental data. Given the current technical indicators and fundamental metrics, a potential forecast could involve a short-term cautious stance due to the bearish short-term trend indicated by the SMA20 and SMA50, alongside a longer-term reevaluation as the stock approaches its SMA200. If the company continues to demonstrate solid financials and growth in line with or exceeding the expectations reflected in its forward P/E, it could potentially stabilize or recover towards its longer-term averages. Investors should closely monitor earnings reports, industry trends, and technical indicators for signs of reversal or continued downtrend.
Additional Sources for ADDV-A Stock
ADDV-A Stock Overview
Market Cap in USD | 55m |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
GiC Sub-Industry | Life Sciences Tools & Services |
IPO / Inception |
ADDV-A Stock Ratings
Growth Rating | 38.9 |
Fundamental | 38.7 |
Dividend Rating | 1.0 |
Rel. Strength | -49.3 |
Analysts | - |
Fair Price Momentum | 2.85 SEK |
Fair Price DCF | 14.42 SEK |
ADDV-A Dividends
Currently no dividends paidADDV-A Growth Ratios
Growth Correlation 3m | -54.5% |
Growth Correlation 12m | -79.2% |
Growth Correlation 5y | 68.9% |
CAGR 5y | 37.71% |
CAGR/Max DD 5y | 0.47 |
Sharpe Ratio 12m | -0.57 |
Alpha | -62.38 |
Beta | 0.833 |
Volatility | 65.66% |
Current Volume | 0.4k |
Average Volume 20d | 51.4k |
As of July 01, 2025, the stock is trading at SEK 3.03 with a total of 431 shares traded.
Over the past week, the price has changed by -2.88%, over one month by -10.09%, over three months by -39.64% and over the past year by -52.05%.
Partly, yes. Based on ValueRay´s Fundamental Analyses, ADDvise (ST:ADDV-A) is currently (July 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 38.73 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ADDV-A is around 2.85 SEK . This means that ADDV-A is currently overvalued and has a potential downside of -5.94%.
ADDvise has no consensus analysts rating.
According to our own proprietary Forecast Model, ADDV-A ADDvise will be worth about 3.1 in July 2026. The stock is currently trading at 3.03. This means that the stock has a potential upside of +1.65%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 13 | 329% |
Analysts Target Price | - | - |
ValueRay Target Price | 3.1 | 1.7% |